News

Walgreens expands vaccine availability across Florida store base

BY Michael Johnsen

DEERFIELD, Ill. — Walgreens on Monday expanded vaccine availability at all of its more than 800 locations across Florida as new state legislation takes effect to help bring greater patient access to vaccines.
 
Pharmacists in the Sunshine state are now authorized to provide the Centers for Disease Control and Prevention recommended meningococcal (meningitis) vaccines for patients 18 years and older, and zoster (shingles) vaccines for patients 60 years and older, in addition to influenza and pneumococcal vaccinations available to eligible patients ages 18 and older.
 
“As some of the most trusted healthcare professionals in communities across Florida, this is an excellent opportunity for our pharmacists to help educate residents about the importance of adult vaccinations and to improve immunization rates through greater access,” said Terry Gubbins, Florida market pharmacy director for Walgreens. “We’ve demonstrated through flu seasons and other health initiatives the important role Walgreens is playing in health care today, providing high quality, affordable care to help more people get, stay and live well.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Sandoz launches generic Tobi

BY Ryan Chavis

PRINCETON, N.J. — Sandoz on Monday announced the introduction of tobramycin inhalation solution, USP into the U.S. market. The drug is an authorized generic version of Tobi from Novartis.

The drug is used for the management of cystic fibrosis in patients whose lungs contain bacteria called P. aeruginosa, the company said. Cystic fibrosis is a life-threatening disease that affects the lungs and digestive system. It's estimated that 30,000 children and adults in the United States suffer from the disease.

"We are proud to bring the authorized generic of Tobi to the patients with cystic fibrosis,” said Peter Goldschmidt, president of Sandoz US. “As part of the Novartis Group, we work together to increase patient access to leading treatments in the most efficient and effective way possible.”

Sales for the the branded version of tobramycin inhalation solution, USP were approximately $241 million for the 12 months ended April 2014, according to IMS Health. Sandoz will be marketing the drug in 300-mg single-dose ampules, the same size and strength that is currently being marketed by the brand.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Pure Encapsulations launches line of probiotics using freeze-drying technology

BY Michael Johnsen

SUDBURY, Mass. — Pure Encapsulations recently launched PureBiOme, a line of probiotics using proprietary PureBiOme freeze-drying technology, which enables probiotics to maintain potency when combined with active ingredients for the first time. 
 
“The proprietary freeze-drying technology implemented for the PureBiOme line limits the water activity within the capsule, keeping the organisms in a quiescent, yet stable state,” said Juniper Devecis, director of product development at Pure Encapsulations. “This is critical in order to effectively combine probiotic bacterial strains with other active ingredients that would otherwise negatively impact their viability.” 
 
The PureBiOme product line offers four formulas that each combine a 4-strain blend of probiotics with a selection of active ingredients, including Saccharomyces boulardii (helps lessen occasional diarrhea), l-glutamine (gastorintestinal comfort), broccoli concentrate (liver cell health) or cranberry extract (genitourinary support) for condition-specific support, the company noted. 
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES